|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
EXP |
Amikacin results in decreased expression of ABCC3 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression |
EXP |
Amikacin results in decreased expression of ABCC4 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Casr |
calcium-sensing receptor |
increases activity |
ISO |
Amikacin results in increased activity of CASR protein |
CTD |
PMID:19884751 |
|
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
ISO |
Amikacin results in decreased activity of CAT protein cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein] |
CTD |
PMID:18781908 PMID:23416261 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
Amikacin results in decreased expression of IL1A mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
ISO |
Amikacin results in decreased expression of IL1B mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il24 |
interleukin 24 |
decreases expression |
ISO |
Amikacin results in decreased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases activity |
EXP |
Amikacin results in decreased activity of PGD protein |
CTD |
PMID:15558954 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
increases expression |
ISO |
Amikacin results in increased expression of PID1 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Amikacin results in decreased expression of PTGS2 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
Amikacin results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Amikacin results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Tyr |
tyrosinase |
decreases activity |
ISO |
Amikacin results in decreased activity of TYR protein |
CTD |
PMID:23416261 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
Kanamycin results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Diaph1 |
diaphanous-related formin 1 |
multiple interactions decreases expression |
ISO |
Kanamycin inhibits the reaction [DIAPH1 binds to RHOA] Kanamycin results in decreased expression of DIAPH1 protein |
CTD |
PMID:16521128 |
|
NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases phosphorylation |
EXP |
Kanamycin results in increased phosphorylation of JUN protein |
CTD |
PMID:17570507 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
EXP |
Kanamycin results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:17570507 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
multiple interactions |
ISO |
Kanamycin promotes the reaction [RAC1 binds to NCF2] |
CTD |
PMID:16521128 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Prdx3 |
peroxiredoxin 3 |
multiple interactions increases expression |
ISO |
2,3-dihydroxybenzoic acid promotes the reaction [Kanamycin results in increased expression of PRDX3 protein] Kanamycin results in increased expression of PRDX3 mRNA; Kanamycin results in increased expression of PRDX3 protein |
CTD |
PMID:23626763 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
Kanamycin promotes the reaction [RAC1 binds to NCF2] |
CTD |
PMID:16521128 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions increases expression decreases expression |
ISO |
Kanamycin inhibits the reaction [DIAPH1 binds to RHOA] Kanamycin results in increased expression of RHOA protein Kanamycin results in decreased expression of RHOA protein |
CTD |
PMID:16521128 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
affects response to substance |
ISO |
SLC1A3 affects the susceptibility to Kanamycin |
CTD |
PMID:15862894 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
decreases activity |
EXP |
Tobramycin results in decreased activity of ANPEP protein |
CTD |
PMID:6653171 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
B2m |
beta-2 microglobulin |
increases expression |
ISO |
Tobramycin results in increased expression of B2M protein |
CTD |
PMID:2218653 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Ctsb |
cathepsin B |
affects activity |
EXP |
Tobramycin affects the activity of CTSB protein |
CTD |
PMID:6653171 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Elane |
elastase, neutrophil expressed |
multiple interactions |
ISO |
[Copper binds to Tobramycin] which results in decreased activity of ELANE protein |
CTD |
PMID:23072509 |
|
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Tobramycin results in increased expression of GADD45A mRNA |
CTD |
PMID:26260164 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Tobramycin results in increased expression of HMOX1 mRNA; Tobramycin results in increased expression of HMOX1 protein |
CTD |
PMID:26260164 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
Tobramycin inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA]; Tobramycin inhibits the reaction [Lipopolysaccharides results in increased secretion of MUC5AC protein] |
CTD |
PMID:21414310 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[Copper binds to Tobramycin] inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] |
CTD |
PMID:23072509 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression |
ISO |
Tobramycin results in increased expression of ZFP36 mRNA |
CTD |
PMID:26260164 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|